Characteristics of AML samples
| Sample no. . | Karyotype . | NPM mutation . | CD34+CD38+ percentage . | CD34+CD38− percentage . |
|---|---|---|---|---|
| 1 | Normal | Present | 0.05 | 0.24 |
| 2 | 48,XY,+3, +10 | Present | 12 | 9.6 |
| 3 | 46,XY,t(11;19)(q23;p13.1) | Not tested | 33 | 0.004 |
| 4 | Normal | Present | 3.1 | 0.074 |
| 5 | Normal | Present | 0.03 | 0.03 |
| 6 | Normal | Not tested | 16 | 1.2 |
| 7 | Normal | Not tested | 52 | 0.048 |
| 8 | 48,XY,+11,+13 | Not tested | 28 | 6 |
| 9 | Normal | Not tested | 7.5 | 0.25 |
| 10 | Normal | Not tested | 54 | 0.006 |
| Sample no. . | Karyotype . | NPM mutation . | CD34+CD38+ percentage . | CD34+CD38− percentage . |
|---|---|---|---|---|
| 1 | Normal | Present | 0.05 | 0.24 |
| 2 | 48,XY,+3, +10 | Present | 12 | 9.6 |
| 3 | 46,XY,t(11;19)(q23;p13.1) | Not tested | 33 | 0.004 |
| 4 | Normal | Present | 3.1 | 0.074 |
| 5 | Normal | Present | 0.03 | 0.03 |
| 6 | Normal | Not tested | 16 | 1.2 |
| 7 | Normal | Not tested | 52 | 0.048 |
| 8 | 48,XY,+11,+13 | Not tested | 28 | 6 |
| 9 | Normal | Not tested | 7.5 | 0.25 |
| 10 | Normal | Not tested | 54 | 0.006 |
NPM indicates nucleophosmin.